Myocardial Dysfunction in Early State of Endotoxemia Role of Heme-Oxygenase-1

Journal of Surgical Research

Volumn 158, Issue 1, 2010, Pages 94-103

  Tamion, Fabienne ^a,b   Bauer, Fabrice ^a,c   Richard, Vincent ^a   Laude, Karine ^a   Renet, Sylvanie ^a   Slama, Michel ^d   Thuillez, Christian ^a  

^a INSERM   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c Cardiology Department   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

cytokine; heme oxygenase 1; LPS; oxidative stress; tissue Doppler imaging

Indexed keywords

HEME OXYGENASE 1; HEMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTRON SPIN RESONANCE; ENDOTOXEMIA; GENE OVEREXPRESSION; HEMODYNAMIC MONITORING; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIAL DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE DOPPLER IMAGING;

ANIMALS; ECHOCARDIOGRAPHY; ENDOTOXEMIA; HEART; HEME OXYGENASE (DECYCLIZING); HEMIN; HEMODYNAMICS; MALE; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 79955481083     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.09.023     Document Type: Article

References (48)

1. Piper R.D. Myocardial dysfunction in sepsis. Clin Exp Pharmacol Physiol 25 (1998) 951
2. McDonough K.H., and Virag J.I. Sepsis-induced myocardial dysfunction and myocardial protection from ischemia/reperfusion injury. Front Biosci 11 (2006) 23
3. Rudiger A., and Mervyn S. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35 (2007) 1599
4. Chopra M., and Sharma A.C. Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction. Life Sci 81 (2007) 306
5. Brahmbhatt S., Gupta A., and Sharma A.C. Big endothelin-1 (1-21) fragment during early sepsis modulates tau, p38-MAPK phosphorylation and nitric oxide synthase activation. Mol Cell Biochem 271 (2005) 225
6. Derumeaux G., Ovize M., Loufoua J., et al. Doppler tissue imaging quantitates regional wall motion during myocardial ischemia and reperfusion. Circulation 97 (1989) 1970
7. Annane D., Bellissant E., and Cavaillon J.M. Septic shock. Lancet 365 (2005) 63
8. Lopez-Bojorquez L.N., Dehesa A.Z., and Reyes-Teran G. Molecular mechanisms involved in the pathogenesis of septic shock. Arch Med Res 35 (2004) 465
9. Parker M.M., McCarthy K.E., Ognibene F.P., et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 97 (1999) 126
10. Court O., Kumar A., Parrillo J.E., et al. Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 6 (2002) 500
11. Kumar A., Haery C., and Parrillo J.E. Myocardial dysfunction in septic shock. Crit Care Clin 16 (2000) 251
12. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol 274 (1998) R577
13. Rudiger A., and Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35 (2007) 1599
14. Nakamura K., Fushimi K., Kouchi H., et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II. Circulation 98 (1998) 794
15. Ryter S.W., and Choi A.M. Heme oxygenase-1: Redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal 7 (2005) 80
16. Choi A.M., and Alam J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 15 (1996) 9
17. Elbirt K.K., and Bonkovsky H.L. Heme oxygenase: Recent advances in understanding its regulation and role. Proc Assoc Am Physicians 111 (1999) 438
18. Ryter S.W., and Choi A.M. Heme oxygenase-1: Redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal 7 (2005) 80
19. Immenschuch S., and Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 60 (2000) 1121
20. Hangaishi M., Ishizaka N., Aizawa T., et al. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 279 (2000) 582
21. Yoshida T., Maulik N., Ho Y.S., et al. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene. Circulation 103 (2001) 1695
22. Yet S.F., Tian R., Layne M.D., et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89 (2001) 168
23. Clark J.E., Foresti R., Sarathchandra P., et al. Heme oxygenase-1 derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278 (2000) H643
24. Tamion F., Richard V., Lacoume Y., et al. Intestinal preconditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1. Am J Physiol Gastrointest Liver Physiol 283 (2002) G408
25. Yet S.F., Tian R., Layne M.D., et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89 (2001) 168
26. Clark J.E., Foresti R., Sarathchandra P., et al. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278 (2000) H643
27. Supinski G.S., and Callahan L.A. Hemin prevents cardiac and diaphragm mitochondrial dysfunction in sepsis. Free Radic Biol Med 40 (2006) 127
28. Engberding N., Spiekermann S., Schaefer A., et al. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: A new action for an old drug?. Circulation 110 (2004) 2175
29. Matsushima S., Ide T., Yamato M., et al. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 113 (2003) 1779
30. Murdoch C.E., Zhang M., Cave A.C., et al. NADPH oxidase-dependent redox signaling in cardiac hypertrophy, remodeling, and failure. Cardiovasc Res 71 (2006) 208
31. Kinugawa S., Tsutsui H., and Hayashidani S. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: Role of oxidative stress. Circ Res 87 (2000) 392
32. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Investig 115 (2005) 500
33. Ide T., Tsutsui H., Hayashidani S., et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 88 (2001) 529
34. Court O., Kumar A., Parrillo J.E., et al. Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 6 (2002) 500
35. Machida Y., Kubota T., Kawamura N., et al. Overexpression of tumor necrosis factor-α increases production of hydroxyl radical in murine myocardium. Am J Physiol Heart Circ Physiol 284 (2003) H449
36. Kubota T., Miyagishima M., Frye C.S., et al. Overexpression of tumor necrosis factor-α activates both anti- and pro-apoptotic pathways in the myocardium. J Mol Cell Cardiol 33 (2001) 1331
37. Suematsu N., Tsutsui H., Wen J., et al. Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107 (2003) 1418
38. Corda S., Laplace C., Vicaut E., et al. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol 24 (2001) 762
39. Oral H., Dorn G.W., and Mann D.L. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 272 (1997) 4836
40. Moe G.W., Marin-Garcia J., Konig A., et al. In vivo TNFα inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol Heart Circ Physiol 287 (2004) H1813
41. Takahashi T., Morita K., Akagi R., et al. Heme oxygenase-1: A novel therapeutic target in oxidative tissue injuries. Curr Med Chem 11 (2004) 1545
42. Tamion F., Richard V., Lacoume Y., et al. Intestinal preconditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1. Am J Physiol Gastrointest Liver Physiol 283 (2002) G408
43. Clark J.E., Foresti R., Sarathchandra P., et al. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278 (2000) H643
44. Hangaishi M., Ishizaka N., Aizawa T., et al. Induction of heme oxygenase-1 can act protectively against cardiac ischemia/reperfusion in vivo. Biochem Biophys Res Commun 279 (2000) 582
45. Wiesel P., Patel A.P., DiFonzo N., et al. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102 (2000) 3015
46. Scott J.R., Chin B.Y., Bilban M.H., et al. Restoring Homeostasis: Is heme oxygénase-1 ready for the clinic?. Trends Pharmacol Sci 28 (2007) 200
47. Overhaus M., Moore B.A., Barbato J.E., et al. Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol Gastrointest Liver Physiol 290 (2005) G695
48. Sarady-Andrews J.K., Liu F., Gallo D., et al. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 289 (2005) L1131